Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Astrana Health, Inc.

Astrana Health, Inc. (ASTH) Stock Overview

Explore Astrana Health, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ASTH●NASDAQ
HealthcareMedical - Care Facilities
$36.51
$1.46(3.85%)
U.S. Market opens in 10h 10m

Astrana Health, Inc. (ASTH)

Meyka AI Score

Z

Key Financials

Market Cap1.8B
P/E Ratio59.62
EPS (TTM)$1.48
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 Month$49.97
3 Months$60.57
1 Year Target$28.25

ASTH Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Astrana Health, Inc. (NASDAQ: ASTH) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Astrana Health, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ASTH on the NASDAQ shows an RSI of 28.89, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $28.25 for the NASDAQ listing.

Key metrics behind Astrana Health, Inc.'s NASDAQ-traded stock include a P/E ratio of 59.62 and a market capitalization of 1.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ASTH on the NASDAQ.

Price Performance (NASDAQ: ASTH)

1-Day Change
-3.85%
5-Day Change
-10.71%
1-Month Change
-18.92%
3-Month Change
4.25%
6-Month Change
62.92%
Year-to-Date (YTD) Change
47.16%
1-Year Change
55.83%
3-Year Change
-0.33%
5-Year Change
-63.15%
All-Time (Max) Change
288.40%

Contact Information

https://www.astranahealth.com
626 282 0288
1668 S. Garfield Avenue, Alhambra, CA, 91801

Company Facts

30,000 Employees
IPO DateMar 11, 2009
CountryUS
Actively Trading

Frequently Asked Questions